Comparing 2 hypotheses side-by-side
CSF soluble PDGFR-β shedding from pericytes as the earliest detectable molecular event in AD, preceding amyloid/tau pathology and exploitable as a 'zero-stage' biomarker via ADAM10/17-mediated ectodomain shedding. Biomarker utility is strong; therapeutic translation requires novel PDGFR-β agonism or ADAM10/17-selective CNS inhibition.
## Mechanistic Overview Pericyte Contractility Reset via Selective PDGFR-β Agonism starts from the claim that modulating PDGFRB within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## **Molecular Mechanism and Rationale** Pericytes are contractile cells that wrap around capillaries and play a crucial role in maintaining blood-brain barrier (BBB) integrity, regulating cerebral blood flow, and facilitating interstitial fluid drai
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
| Dimension | Pericyte-First Sequential Biom | Pericyte Contractility Reset v |
|---|---|---|
| Mechanistic | 0.820 | 0.500 |
| Evidence | 0.180 | 0.450 |
| Novelty | 0.760 | 0.900 |
| Feasibility | 0.680 | 0.300 |
| Impact | 0.000 | 0.600 |
| Druggability | 0.420 | 0.250 |
| Safety | 0.480 | 0.350 |
| Competition | 0.650 | 0.950 |
| Data | 0.800 | 0.550 |
| Reproducible | 0.740 | 0.500 |
| KG Connect | 0.500 | 0.706 |
No evidence citations yet
No evidence citations yet
4 rounds · quality: 1.00
# Mechanistic Hypotheses: BBB Permeability as Early Neurodegeneration Biomarker --- ## Hypothesis 1: Caveolin-1-Mediated Transcytosis Upregulation Precedes Paracellular Tight Junction Loss in Earl...
# Critical Evaluation: BBB Permeability as Early Neurodegeneration Biomarker Let me work through your hypothesis systematically. You've laid out a mechanistically sophisticated framework, which mak...
# Domain Expert Evaluation: BBB Permeability as Neurodegeneration Biomarker ## 1. Hypotheses with Highest Translational Potential ### Tier 1: Plasma GFAP/NFL as Accessible BBB Permeability Markers...
{ "ranked_hypotheses": [ { "rank": 1, "title": "Plasma GFAP/NFL as Early BBB Permeability Markers", "mechanism": "Astrocyte injury and BBB dysfunction release GFAP into circu...
4 rounds · quality: 0.93
# Novel Therapeutic Hypotheses for Perivascular Spaces and Glymphatic Clearance in AD ## 1. Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation **Description:** Chronic activation of ...
# Novel Therapeutic Hypotheses for Perivascular Spaces and Glymphatic Clearance in AD ## 1. Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation **Description:** Chronic activation of ...
# Critical Scientific Evaluation of Glymphatic Therapeutic Hypotheses ## 1. Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation ### Critical Weaknesses: - **Mechanistic gap**: The con...
# Critical Scientific Evaluation of Glymphatic Therapeutic Hypotheses ## 1. Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation ### Critical Weaknesses: - **Mechanistic gap**: The con...
Curated mechanism pathway diagrams from expert analysis
graph TD
A["PDGFR-beta Selective Agonist"]
B["PDGFR-beta Receptor Activation"]
C["PLCgamma Pathway Activation"]
D["IP3 and DAG Generation"]
E["Calcium Mobilization"]
F["Protein Kinase C Activation"]
G["Myosin Light Chain Phosphorylation"]
H["Pericyte Contractility Enhancement"]
I["Blood-Brain Barrier Stabilization"]
J["Glymphatic Flow Restoration"]
K["Amyloid-beta Clearance"]
L["Neuroinflammation Reduction"]
M["Synaptic Protection"]
N["Cognitive Function Improvement"]
O["Neurodegeneration Progression Halt"]
P["PI3K/Akt Pathway Inhibition"]
A -->|"therapeutic intervention"| B
B -->|"selective signaling"| C
B -->|"alternative pathway"| P
C -->|"phospholipase activation"| D
D -->|"second messenger generation"| E
D -->|"protein kinase activation"| F
E -->|"intracellular Ca2+ increase"| G
F -->|"contractile protein regulation"| G
G -->|"smooth muscle contraction"| H
H -->|"vascular tone restoration"| I
H -->|"perivascular space regulation"| J
I -->|"barrier function improvement"| K
J -->|"interstitial fluid drainage"| K
K -->|"protein aggregate removal"| L
L -->|"neuroprotective environment"| M
M -->|"neuronal preservation"| N
N -->|"functional recovery"| O
P -->|"proliferation inhibition"| H
classDef mechanism fill:#4fc3f7
classDef pathology fill:#ef5350
classDef therapy fill:#81c784
classDef outcome fill:#ffd54f
classDef genetics fill:#ce93d8
class A,B,C,D,E,F,G,P therapy
class H,I,J mechanism
class K,L,M outcome
class N,O outcome